pulmonari
fibrosi
pf
repres
end
stage
pulmonari
inflamm
injuri
histopatholog
characterist
includ
absolut
increas
collagen
content
excess
number
inflammatori
cell
remark
abnorm
ultrastructur
appear
mesenchym
accumul
collagenrich
extra
cellular
matrix
ecm
damag
alveolar
wall
loss
function
capillari
unit
lead
respiratori
failur
within
year
follow
diagnost
confirm
giri
patient
suffer
chronic
diseas
well
acut
damag
sever
acut
respiratori
syndrom
sar
may
develop
typic
pf
patient
eventu
die
cheung
et
al
base
publish
report
estim
incid
pf
usa
european
countri
estim
correspond
author
tel
fax
email
address
xumin
hkbueduhk
xu
cost
healthcar
us
per
patient
raghu
et
al
pf
result
mani
endogen
exogen
caus
infect
chemic
poison
radiat
etc
bleomycininduc
pulmonari
fibrosi
blmpf
rat
wide
use
model
investig
patholog
pf
giri
recent
year
number
studi
show
signific
upregul
induc
nitric
oxid
synthetas
ino
transform
growth
lung
tissu
blmpf
rat
resembl
clinic
find
pf
patient
khalil
et
al
gurujeyalakshmi
et
al
coker
et
al
romanska
et
al
similar
suggest
activ
ino
inflammatori
cell
respons
excess
format
nitric
oxid
involv
pulmonari
injuri
hobb
et
al
meanwhil
result
suggest
deriv
fibroblast
one
key
cytokin
fibrogenet
phase
pf
may
result
collagen
overproduct
deposit
lung
coker
et
al
two
factor
play
import
role
pf
induc
bleomycin
therefor
regard
patholog
marker
research
potenti
therapeut
target
treatment
hobb
et
al
flander
burmest
well
known
pf
hard
treat
clinic
medic
success
reliev
condit
corticosteroid
therapi
firstlin
choic
prevent
treat
diseas
american
thorac
societi
laboratori
studi
show
corticosteroid
might
prevent
collagen
overexpress
dik
et
al
might
decreas
upregul
cytokin
includ
blmpf
model
khalil
et
al
studi
corticosteroid
might
inhibit
ino
overexpress
acut
cardiac
allograft
reject
although
effect
report
pf
worral
et
al
sinc
unaccept
advers
effect
associ
corticosteroid
treatment
search
effect
safer
therapi
one
hot
topic
field
recent
year
report
curcumin
botan
compound
antiinflammatori
antioxid
antitumor
effect
amelior
advers
patholog
chang
blmpf
model
venkatesan
et
al
punithavathi
et
al
thu
appear
potenti
valuabl
treatment
pf
view
lack
knowledg
exact
pharmacodynam
effect
pharmacolog
mechan
curcumin
pf
treatment
compar
therapeut
effect
curcumin
current
standard
therapi
corticosteroid
examin
regul
role
curcumin
protein
mrna
express
ino
valuabl
present
studi
blmpf
rat
use
model
histopatholog
examin
includ
stain
masson
stain
immunohistochem
analysi
conduct
identifi
characterist
pf
rat
lung
tissu
express
pulmonari
protein
mrna
coli
ino
quantit
determin
western
blot
realtim
rt
pcr
analys
treatment
curcumin
hydrocortison
fifti
pathogenfre
femal
spraguedawley
rat
bodi
weight
g
purchas
anim
centr
chines
univers
hong
kong
hong
kong
randomli
divid
five
group
ie
neg
control
nc
posit
control
pc
hydrocortison
hc
highdos
curcumin
ch
lowdos
curcumin
cl
group
rat
group
nc
inject
ml
physiolog
salin
intratrach
rat
group
inject
mgkg
bleomycin
sigma
intratrach
induc
blmpf
bleomycin
inject
rat
group
hc
treat
mgkg
hydrocortison
yangzhou
pharm
ltd
china
ip
per
day
three
time
total
rat
group
inject
deioniz
water
alon
accord
schedul
group
ch
cl
rat
oral
given
mgkg
curcumin
henan
guangy
natur
pigment
co
ltd
china
per
day
respect
rat
oral
given
deioniz
water
alon
experi
rat
hous
anim
room
temperaturehumid
control
dark
cycl
allow
take
food
water
ad
libitum
day
intratrach
inject
rat
anesthet
sacrif
lung
heart
liver
kidney
brain
spleen
uteru
collect
anim
left
lung
cut
small
piec
store
c
western
blot
realtim
pcr
analys
organ
kept
formaldehyd
solut
histolog
analys
includ
stain
masson
stain
immunohistochem
analysi
day
intratrach
inject
ml
blood
sampl
rat
collect
posterior
venou
plexus
eye
orbit
serum
creatinin
cr
glutamicpyruv
transaminas
gpt
analyz
biochem
kit
protocol
research
approv
anim
experiment
ethic
committe
hong
kong
baptist
univers
fix
formaldehyd
solut
h
block
rat
lung
tissu
dehydr
embed
paraffin
cut
slice
incub
c
overnight
dewax
final
stain
hematoxylineosin
masson
trichrom
sampl
organ
also
prepar
stain
hematoxylineosin
similarli
toxic
assess
slice
immunohistochem
analysi
treat
c
dewax
rehydr
equilibr
tri
buffer
salin
tb
contain
triton
sigma
endogen
peroxid
activ
block
use
h
sigma
methanol
min
slice
treat
trypsin
tri
cacl
ph
nonspecif
bind
elimin
block
normal
goat
serum
santa
cruz
tb
bovin
serum
albumin
bsa
subsequ
slice
incub
overnight
c
primari
antibodi
goat
polyclon
igg
rat
coli
rabbit
polyclon
igg
rat
ino
rabbit
polyclon
igg
rat
santa
cruz
tb
bsa
follow
incub
secondari
antibodi
rabbit
antigoat
igghrp
coli
goat
antirabbit
igghrp
ino
santa
cruz
tb
bsa
dilut
incub
avidin
biotin
complex
santa
cruz
tb
bsa
h
develop
conduct
diaminolunzidin
sigma
h
tri
nacl
ph
min
final
slice
counterstain
gill
haematoxylin
dehydr
mount
permont
sigma
studi
neg
control
primari
antibodi
ad
incub
use
verifi
result
immunohistochem
analys
five
lung
sampl
group
randomli
select
protein
express
coli
ino
determin
western
blot
analys
cell
lysat
prepar
frozen
lung
tissu
homogen
c
proteas
inhibitor
phosphatas
inhibitor
santa
cruz
ice
incub
homogen
centrifug
g
min
c
supernat
fluid
gather
total
cell
lysat
g
whole
cell
lysat
mix
equal
volum
electrophoresi
sampl
buffer
contain
glycerol
sodium
dodecyl
sulfat
trishcl
ph
bromophenol
blue
boil
min
l
lysat
mixtur
load
polyacryamid
gel
electrophoresi
biorad
meanwhil
nitrocellulos
membran
pretreat
dh
blot
buffer
electrophoresi
polyacryamid
gel
place
wick
cover
nitrocellulos
membran
wet
paper
whatman
left
electroblot
apparatu
overnight
transfer
protein
gel
nitrocellulos
membran
nitrocellulos
membran
subsequ
treat
block
reagent
min
incub
primari
antibodi
goat
polyclon
igg
rat
coli
rabbit
polyclon
igg
rat
ino
rabbit
polyclon
igg
rat
mous
monoclon
igg
santa
cruz
phosphat
buffer
solut
pb
h
secondari
antibodi
rabbit
antigoat
iggap
coli
goat
antirabbit
iggap
ino
goat
antimous
iggap
santa
cruz
pb
min
develop
solut
mixtur
ml
dh
ml
buffer
concentr
ml
nitroblu
tetrazolium
solut
ml
phosphat
solut
min
final
rins
dh
stop
reaction
order
control
interand
intraassay
variat
use
intern
control
level
coli
ino
protein
repres
ratio
coli
ino
respect
five
lung
sampl
group
randomli
select
mrna
express
coli
ino
determin
realtim
rt
pcr
analys
total
rna
lung
sampl
extract
use
rna
isol
purif
kit
qiagen
follow
instruct
rna
concentr
determin
uvvi
spectrophotomet
hitachi
japan
nm
l
total
rna
denatur
c
min
mix
l
reaction
system
contain
buffer
solut
mm
trishcl
mm
kcl
mm
mgcl
mm
dtt
mmoll
dntp
mmlv
revers
transcriptas
depctreat
water
system
allow
react
c
h
termin
c
min
complet
reversetranscript
cours
obtain
cdna
solut
l
cdna
ad
l
reaction
volum
contain
l
taq
dna
polymeras
mmoll
dntp
mmoll
mgcl
mmoll
target
primer
gene
sequenc
list
tabl
pcr
amplif
quantif
conduct
thermocycl
pe
perkin
elmer
usa
accord
follow
protocol
solut
predenatur
c
denatur
c
anneal
c
extend
c
amplifi
cycl
level
coli
ino
mrna
sampl
display
copi
number
target
mrna
per
microgram
total
rna
serum
glutamicpyruv
transaminas
gpt
creatinin
cr
analyz
use
biochem
kit
nanj
jiancheng
bioeng
in
china
uvvi
spectrophotomet
hitachi
japan
nm
respect
data
analyz
statist
packag
social
scienc
spss
version
window
oneway
analysi
varianc
anova
use
determin
whether
intragroup
differ
exist
signific
two
group
evalu
fisher
leastsignificantdiffer
lsd
comparison
procedur
post
hoc
scheff
analysi
pvalu
less
twotail
test
accept
signific
tabl
primer
probe
coli
ino
sequenc
primer
probe
length
fig
display
four
imag
stain
masson
stain
show
lung
tissu
sampl
group
nc
normal
pulmonari
architectur
thinlin
alveolar
septa
normal
cellular
alveolar
macrophag
sampl
group
pc
typic
fibrot
chang
includ
infiltr
excess
inflammatori
cell
fig
larg
collagen
deposit
larg
fibrou
area
collaps
alveolar
space
fig
addit
telangiectasi
hyperemia
thrombogenesi
bronchiol
stegnosi
wider
mesenchym
also
found
sampl
group
pc
view
light
microscop
fig
show
result
immunohistochem
analys
coli
ino
express
distribut
rat
lung
sampl
compar
group
nc
abnorm
chang
found
group
pc
sampl
show
significantli
strong
express
three
protein
neg
control
anova
indic
intragroup
differ
protein
coli
f
p
ino
f
p
f
p
mrna
coli
f
p
ino
f
p
f
p
lsd
comparison
show
signific
differ
two
group
p
p
vs
group
nc
respect
p
p
p
vs
group
pc
respect
present
appar
nonspecif
color
target
protein
tabl
show
result
western
blot
analysi
quantit
determin
three
protein
follow
immunohistochem
analysi
compar
group
nc
protein
express
coli
ino
fig
western
blot
analysi
coli
ino
protein
lung
sampl
rat
result
show
bleomycininduc
overexpress
pulmonari
coli
ino
protein
group
pc
downregul
group
hc
ch
cl
treatment
hydrocortison
highdos
lowdos
curcumin
respect
outcom
determin
five
sampl
group
three
replic
sampl
use
intern
control
normal
express
coli
ino
differ
group
group
pc
averag
increas
respect
p
group
hc
ch
cl
coli
express
lower
group
pc
p
respect
ino
express
lower
group
pc
p
respect
express
lower
group
pc
p
also
respect
except
protein
express
group
ch
cl
lower
group
hc
p
signific
differ
protein
express
among
three
treatment
group
p
tabl
also
show
result
realtim
rt
pcr
analysi
compar
group
nc
mrna
express
coli
ino
group
pc
averag
increas
respect
p
group
hc
ch
cl
coli
express
lower
group
pc
p
ino
express
lower
group
pc
p
express
lower
group
pc
p
respect
signific
differ
mrna
express
among
treatment
group
p
biochem
analysi
show
signific
differ
serum
gpt
cr
among
five
group
addit
signific
histolog
abnorm
could
found
fig
western
blot
realtim
rt
pcr
analys
show
bleomycininduc
overexpress
pulmonari
coli
ino
b
c
protein
mrna
level
group
pc
downregul
group
hc
ch
cl
treatment
hydrocortison
highdos
lowdos
curcumin
respect
valu
present
percentag
increas
mean
se
compar
group
nc
measur
five
sampl
group
three
replic
sampl
p
p
p
vs
group
pc
respect
p
vs
group
hc
heart
liver
kidney
brain
spleen
uteru
tissu
rat
studi
histopatholog
characterist
human
pf
includ
fibrogenet
inflammatori
featur
usual
seen
blmpf
anim
model
giri
gong
et
al
studi
pulmonari
fibrot
foci
rat
model
form
day
bleomycin
inject
fibrogenet
chang
signific
fibroblast
prolifer
excess
collagen
deposit
mesenchym
found
lung
sampl
rat
meanwhil
mani
inflammatori
cell
much
exud
infiltr
mesenchym
alveoli
found
repres
typic
inflammatori
chang
sampl
histolog
find
accord
previou
studi
gong
et
al
constitut
evid
reliabl
patholog
rat
model
regard
pulmonari
inflammatori
injuri
fibrosi
end
pf
result
increas
inflamm
relat
cytokin
fibroblast
collagen
synthes
use
immunohistochem
techniqu
could
determin
overexpress
abnorm
distribut
coli
ino
protein
lung
tissu
blmpf
rat
disord
molecular
marker
relat
pulmonari
inflamm
fibrosi
quantit
identifi
western
blot
analysi
confirm
synchron
analysi
transcript
level
studi
clear
coupl
overexpress
three
protein
mrna
result
studi
hint
key
patholog
chang
blmpf
rat
could
result
excess
upregul
coli
ino
gene
overexpress
ino
may
increas
synthesi
import
toxic
molecul
regard
tissu
injuri
while
may
stimul
transcript
factor
nuclear
factorb
nfb
promot
gene
express
consequ
increas
product
gossart
et
al
thu
postul
regulatori
network
includ
ino
may
involv
develop
pulmonari
fibrosi
although
abnorm
increas
ino
lung
tissu
may
peak
day
bleomycin
inject
gurujeyalakshmi
et
al
found
pulmonari
express
ino
protein
mrna
day
higher
blmpf
rat
normal
rat
abnorm
ino
level
indic
inflammatori
injuri
exist
lung
experiment
rat
end
experi
meanwhil
overexpress
protein
mrna
pulmonari
shown
day
blmpf
rat
may
anoth
import
caus
factor
play
key
role
process
pulmonari
fibrosi
increas
synthesi
secret
ecm
protein
stimul
gene
transcript
decreas
degrad
ecm
inhibit
secret
protein
kinas
robert
et
al
well
known
coli
express
regul
therefor
depress
overexpress
ino
may
inhibit
coli
increas
collagen
synthesi
import
therapeut
target
prevent
pf
corticosteroid
classic
categori
antiinflammatori
reagent
shown
effect
pf
treatment
anim
studi
khalil
et
al
dik
et
al
data
indic
hydrocortison
could
decreas
overexpress
pulmonari
coli
ino
normal
level
day
bleomycin
inject
especi
work
first
observ
show
downregul
increas
ino
express
caus
hydrocortison
treatment
provid
new
evid
explain
antiinflammatori
mechan
therapeut
signific
corticosteroid
pf
treatment
furthermor
parallel
downregul
coli
ino
protein
mrna
level
hydrocortison
treatment
suggest
amelior
coli
may
least
partli
result
inhibit
ino
express
consequ
decreas
express
curcumin
treatment
daili
gavag
mgkg
could
also
significantli
downregul
excess
coli
ino
express
blmpf
rat
except
level
protein
signific
differ
rat
receiv
hydrocortison
treatment
highand
lowdos
curcumin
treatment
find
suggest
curcumin
may
play
similar
role
hydrocortison
prevent
develop
pf
induc
bleomycin
previou
studi
found
curcumin
like
corticosteroid
could
decreas
product
tumor
necrosi
downregul
ino
synthesi
inhibit
infiltr
inflammatori
cell
blmpf
rat
li
et
al
punithavathi
et
al
chu
et
al
evid
indic
curcumin
corticosteroid
might
regul
key
cytokin
inflammatori
respons
play
similar
role
pf
treatment
sever
studi
present
evid
explor
mechan
curcumin
treatment
pf
instanc
nuclear
factor
b
nfb
transcript
factor
conjug
flank
sequenc
ino
gene
contribut
greatli
ino
upregul
respons
variou
proinflammatori
stimuli
chu
et
al
curcumin
abolish
activ
nfb
induc
proinflammatori
factor
interleukin
il
lipopolysaccharid
xu
et
al
xu
et
al
data
suggest
decreas
upregul
pulmonari
ino
blmpf
rat
may
partli
due
curcumin
effect
inhibit
nfb
furthermor
studi
show
receptor
type
ii
ii
necessari
activ
curcumin
could
reduc
ii
express
fibrot
model
use
renal
fibroblast
gaedek
et
al
branton
kopp
curcumin
may
inhibit
dnabind
activ
activ
inhibit
ii
bind
site
locat
ii
promot
gaedek
et
al
xu
et
al
xu
et
al
therefor
reason
presum
downregul
curcumin
administr
current
studi
may
involv
ii
reduct
partli
result
curcumin
suppress
activ
although
precis
mechan
curcumin
regul
cytokin
involv
pulmonari
inflammatori
injuri
fibrosi
remain
uncertain
may
differ
corticosteroid
data
studi
provid
new
clue
investig
corticosteroid
commonli
blame
advers
effect
clinic
experiment
studi
abnorm
chang
biochem
histopatholog
paramet
found
hydrocortison
inject
rat
studi
dose
durat
hydrocortison
design
studi
may
low
short
display
toxic
report
administr
curcumin
mgkgday
continu
day
produc
advers
effect
rat
wo
et
al
data
confirm
dose
safe
rat
treatment
even
daili
dose
mgkg
recommend
futur
studi
pharmacodynam
effect
prevent
blmpf
similar
daili
dose
mgkg
conclus
compar
efficaci
safeti
curcumin
hydrocortison
blmpf
rat
model
data
indic
curcumin
possess
therapeut
effect
compar
hydrocortison
treat
blmpf
rat
oral
administr
curcumin
daili
dose
mgkg
mgkg
significantli
inhibit
bleomycininduc
overexpress
coli
ino
transcript
translat
level
reduc
pulmonari
inflammatori
injuri
fibrosi
signific
differ
treatment
two
dosag
curcumin
wide
use
food
addit
show
advers
effect
studi
therefor
could
valuabl
herbal
compon
pf
treatment
